1. Home
  2. SBFM
  3. SBFM News

Latest Sunshine Biopharma Inc. (SBFM) News on June 29, 2025

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market
SBFM

ACCESS Newswire

18 days ago

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year
SBFM

ACCESS Newswire

a month ago

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market
SBFM

ACCESS Newswire

2 months ago

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

SBFM

MT Newswires

2 months ago

Sunshine Biopharma Unit Rolls Out Afinitor Alternative Everolimus in Canadian Market

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion
SBFM

ACCESS Newswire

2 months ago

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

SBFM

MT Newswires

3 months ago

Sunshine Biopharma Closes $2.5 Million Direct Offering

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering
SBFM

ACCESS Newswire

3 months ago

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
SBFM

ACCESS Newswire

3 months ago

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

SBFM

MT Newswires

3 months ago

Sunshine Biopharma Completes Additional Studies of mRNA Therapy for Liver Cancer; Shares Up Pre-Bell

Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer
SBFM

ACCESS Newswire

3 months ago

Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

SBFM

MT Newswires

3 months ago

Top Premarket Gainers

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year
SBFM

ACCESS Newswire

3 months ago

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

Sunshine Biopharma signs agreement for rights to market two generic antibiotics
SBFM

TipRanks

3 months ago

Sunshine Biopharma signs agreement for rights to market two generic antibiotics

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada
SBFM

ACCESS Newswire

3 months ago

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market
SBFM

ACCESS Newswire

4 months ago

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT
SBFM

ACCESS Newswire

5 months ago

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer
SBFM

ACCESS Newswire

5 months ago

Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer

SBFM

MT Newswires

6 months ago

Sunshine Biopharma Files $100 Million Mixed Shelf; Shares Down

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus
SBFM

ACCESSWIRE

7 months ago

Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus

Sunshine Biopharma Launches a New Generic Prescription Drug
SBFM

ACCESSWIRE

7 months ago

Sunshine Biopharma Launches a New Generic Prescription Drug

Sunshine Biopharma Announces Breakthrough Research Results on the Company’s K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma
SBFM

ACCESSWIRE

7 months ago

Sunshine Biopharma Announces Breakthrough Research Results on the Company’s K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma

Sunshine Biopharma Launches a New Generic Prescription Drug
SBFM

ACCESSWIRE

7 months ago

Sunshine Biopharma Launches a New Generic Prescription Drug

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%
SBFM

ACCESSWIRE

8 months ago

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%

Sunshine Biopharma Launches Two New Generic Prescription Drugs
SBFM

ACCESSWIRE

9 months ago

Sunshine Biopharma Launches Two New Generic Prescription Drugs

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry
SBFM

ACCESSWIRE

10 months ago

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

Is Sunshine Biopharma, Inc. (SBFM) The Best Rated Penny Stock To Buy According to Analysts?
SBFM

Insider Monkey

10 months ago

Is Sunshine Biopharma, Inc. (SBFM) The Best Rated Penny Stock To Buy According to Analysts?

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada
SBFM

ACCESSWIRE

10 months ago

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%
SBFM

ACCESSWIRE

10 months ago

Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%

Sunshine Biopharma Announces Reverse Stock Split
SBFM

ACCESSWIRE

a year ago

Sunshine Biopharma Announces Reverse Stock Split

Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%
SBFM

ACCESSWIRE

a year ago

Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)
SBFM

ACCESSWIRE

a year ago

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)

Sunshine Biopharma Announces Reverse Stock Split
SBFM

ACCESSWIRE

a year ago

Sunshine Biopharma Announces Reverse Stock Split

Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023
SBFM

ACCESSWIRE

a year ago

Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023

Sunshine Biopharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
SBFM

Simply Wall St.

a year ago

Sunshine Biopharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering
SBFM

ACCESSWIRE

a year ago

Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering

Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering
SBFM

ACCESSWIRE

a year ago

Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering

11 Hyper-Growth Stocks Billionaires Are Loading Up On
SBFM

Insider Monkey

a year ago

11 Hyper-Growth Stocks Billionaires Are Loading Up On

Moleculin Announces 2023 Year-End Annamycin Clinical Trials Preliminary Data and 2024 Expectations for Multiple Data Readouts and Transition to Pivotal Phase 2B/3
SBFM

PR Newswire

a year ago

Moleculin Announces 2023 Year-End Annamycin Clinical Trials Preliminary Data and 2024 Expectations for Multiple Data Readouts and Transition to Pivotal Phase 2B/3

Analysts Are Optimistic We'll See A Profit From Sunshine Biopharma, Inc. (NASDAQ:SBFM)
SBFM

Simply Wall St.

a year ago

Analysts Are Optimistic We'll See A Profit From Sunshine Biopharma, Inc. (NASDAQ:SBFM)

Loop Industries Announces MOU For US$66 Million of Non-Dilutive Financing from Reed Management, as Part of a Joint Venture for European Infinite Loop(TM) Technology Roll-Out
SBFM

ACCESSWIRE

a year ago

Loop Industries Announces MOU For US$66 Million of Non-Dilutive Financing from Reed Management, as Part of a Joint Venture for European Infinite Loop(TM) Technology Roll-Out

Spectral AI Begins Enrollment in Pivotal Study to Validate DeepView AI® for Burn Injuries
SBFM

GlobeNewswire

a year ago

Spectral AI Begins Enrollment in Pivotal Study to Validate DeepView AI® for Burn Injuries

SBFM

Business Wire

a year ago

The Beachbody Company, Inc. Announces Participation in the 26th Annual Needham Growth Conference

Independent Research Finds 100% Accuracy for Intellicheck Identity Validation Technology
SBFM

Business Wire

a year ago

Independent Research Finds 100% Accuracy for Intellicheck Identity Validation Technology

WISeKey and SEALSQ Launch at CES 2024 in Las Vegas a New Service to Elevate Cryptocurrency Security with Advanced Digital Identification and Robust Multi-Factor Authentication
SBFM

GlobeNewswire

a year ago

WISeKey and SEALSQ Launch at CES 2024 in Las Vegas a New Service to Elevate Cryptocurrency Security with Advanced Digital Identification and Robust Multi-Factor Authentication

Comstock Acquires and Retires Over 2.6 Million Common Shares
SBFM

GlobeNewswire

a year ago

Comstock Acquires and Retires Over 2.6 Million Common Shares

Banzai Executes LOI to Acquire Top Rated Lead Generation Platform, IGLeads
SBFM

GlobeNewswire

a year ago

Banzai Executes LOI to Acquire Top Rated Lead Generation Platform, IGLeads

17EdTech Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement
SBFM

GlobeNewswire

a year ago

17EdTech Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement

Eco Wave Power Commences Sending of Clean Electricity to the Israeli National Electrical Grid
SBFM

PR Newswire

a year ago

Eco Wave Power Commences Sending of Clean Electricity to the Israeli National Electrical Grid

42West Rebrands BHI to Fandoms & Franchises
SBFM

ACCESSWIRE

a year ago

42West Rebrands BHI to Fandoms & Franchises

The Beachbody Company Celebrates Second Annual World Health Esteem Month This January
SBFM

Business Wire

a year ago

The Beachbody Company Celebrates Second Annual World Health Esteem Month This January

Banzai Celebrates a Year of Unprecedented Growth and Innovation in 2023
SBFM

GlobeNewswire

2 years ago

Banzai Celebrates a Year of Unprecedented Growth and Innovation in 2023

Calculating The Intrinsic Value Of The Cato Corporation (NYSE:CATO)
SBFM

Simply Wall St.

2 years ago

Calculating The Intrinsic Value Of The Cato Corporation (NYSE:CATO)

SBFM

Business Wire

2 years ago

The Beachbody Company, Inc. Announces Participation in the 2024 ICR Conference

15 Best Falling Stocks To Buy Now
SBFM

Insider Monkey

2 years ago

15 Best Falling Stocks To Buy Now

Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease
SBFM

ACCESSWIRE

2 years ago

Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease

Astrotech Announces Exciting New Technology Application and Introduces New Subsidiary
SBFM

GlobeNewswire

2 years ago

Astrotech Announces Exciting New Technology Application and Introduces New Subsidiary

RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
SBFM

PR Newswire

2 years ago

RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split
SBFM

GlobeNewswire

2 years ago

Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split

Sunshine Biopharma Moves Principal Office to New York City
SBFM

GlobeNewswire

2 years ago

Sunshine Biopharma Moves Principal Office to New York City

10 Best Debt Free Penny Stocks To Buy Now
SBFM

Insider Monkey

2 years ago

10 Best Debt Free Penny Stocks To Buy Now

Is It Too Late To Consider Buying Live Ventures Incorporated (NASDAQ:LIVE)?
SBFM

Simply Wall St.

2 years ago

Is It Too Late To Consider Buying Live Ventures Incorporated (NASDAQ:LIVE)?

TRX Gold Reports Year-End 2023 Results
SBFM

GlobeNewswire

2 years ago

TRX Gold Reports Year-End 2023 Results

AmpliTech Group, Inc. Discusses 2023 Revenue Projections and 2024 Technology Applications with The Stock Day Podcast
SBFM

ACCESSWIRE

2 years ago

AmpliTech Group, Inc. Discusses 2023 Revenue Projections and 2024 Technology Applications with The Stock Day Podcast

Snail, Inc. To Participate in Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference
SBFM

GlobeNewswire

2 years ago

Snail, Inc. To Participate in Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference

Syncona to Acquire Freeline Therapeutics
SBFM

GlobeNewswire

2 years ago

Syncona to Acquire Freeline Therapeutics

Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference
SBFM

GlobeNewswire

2 years ago

Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference

Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency
SBFM

GlobeNewswire

2 years ago

Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency

Purple Introduces Two New Pillows That Offer Deeper Sleep Through Customization and Portability
SBFM

PR Newswire

2 years ago

Purple Introduces Two New Pillows That Offer Deeper Sleep Through Customization and Portability

SBFM

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Cara Therapeutics Inc Earnings Call

Cara (CARA) Reports Q3 Earnings: What Key Metrics Have to Say
SBFM

Zacks

2 years ago

Cara (CARA) Reports Q3 Earnings: What Key Metrics Have to Say

Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition
SBFM

ACCESSWIRE

2 years ago

Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition

SBFM

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Nortech Systems Inc Earnings Call

NeoVolta Expands its Emerging Presence Across America by Adding $520,000 Purchase Order for Residential Solar Battery Storage in New Mexico
SBFM

GlobeNewswire

2 years ago

NeoVolta Expands its Emerging Presence Across America by Adding $520,000 Purchase Order for Residential Solar Battery Storage in New Mexico

Nortech Systems Inc (NSYS) Reports Mixed Q3 2023 Results Amid Strong Backlog
SBFM

GuruFocus.com

2 years ago

Nortech Systems Inc (NSYS) Reports Mixed Q3 2023 Results Amid Strong Backlog

Intellinetics to Host Third Quarter 2023 Financial Results Conference Call on November 14
SBFM

Business Wire

2 years ago

Intellinetics to Host Third Quarter 2023 Financial Results Conference Call on November 14

Citizens, Inc. Reports Third Quarter 2023 Financial Results
SBFM

Newsfile

2 years ago

Citizens, Inc. Reports Third Quarter 2023 Financial Results

BowFlex Inc. to Announce Fiscal Second Quarter 2024 Results on Tuesday, November 14, 2023
SBFM

Business Wire

2 years ago

BowFlex Inc. to Announce Fiscal Second Quarter 2024 Results on Tuesday, November 14, 2023

ATI Physical Therapy Achieves 'Exceptional' Rating in Patient Quality for 4th Consecutive Year
SBFM

PR Newswire

2 years ago

ATI Physical Therapy Achieves 'Exceptional' Rating in Patient Quality for 4th Consecutive Year

Solid Power Announces Upcoming Investor Conference Schedule
SBFM

GlobeNewswire

2 years ago

Solid Power Announces Upcoming Investor Conference Schedule

GigCapital5, Inc. Confirms Receipt of Sponsor Funds for Additional Working Capital
SBFM

Business Wire

2 years ago

GigCapital5, Inc. Confirms Receipt of Sponsor Funds for Additional Working Capital

Share on Social Networks: